Novartis AG Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (49)

Latest Posts

About This Stock More About This Stock
A Secure And Growing Dividend In Healthcare
Article By: Marc Lichtenfeld
Wednesday, January 4, 2017 4:56 PM EST
Novartis has an excellent dividend-paying track record, raising its distribution every year for 19 years with no cuts.
In this article: NVS
Read
J&J Back In Talks With Actelion, Teva Settles Corruption Probe
Article By: Arpita Dutt
Friday, December 23, 2016 1:37 PM EST
Several tuck-in deals and licensing agreements were announced this week while healthcare giant Johnson & Johnson is back in exclusive talks with Actelion regarding a possible deal.
In this article: AGN, JNJ, MRK, NVS, TEVA Also: BMY, PFE, LLY
Read
These 8 Top Dividend Stocks Are Also ADRs - Check Them Out
Article By: Lorimer Wilson
Tuesday, December 13, 2016 8:00 AM EST
An ADR is an issued certificate that represents shares of a foreign stock. They trade on U.S. exchanges and are not subject to foreign taxes or fees. This post identifies and describes 8 of the top dividend ADRs.
In this article: DEO, GSK, NVS, TOT, NSRGY, INFY, TEVA, SIEGY
Read
Biotechs Mixed Hurt By Alexion And Ophthotech
Article By: Rod Raynovich
Monday, December 12, 2016 11:03 PM EST
Alexion - Company Fired its CEO and CFO on Sales Practices. Board member David Brennan and former CEO of AstraZeneca will take the helm. The third quarter report has been delayed on accounting issues and will be filed by mid - January.
In this article: LMT, NVS, ALXN, ARRY, IBB, REGN, AMGN, GILD, XBI, XLV, ABBV, BLUE, OPHT
Read
Week In Review: JHL Biotech Signs $257 Million Biosimilar Deal With Sanofi
Article By: ChinaBio® Today
Saturday, December 10, 2016 12:44 PM EST
JHL Biotech, a Taiwan-China biologics company, signed a $257 million partnership agreement that gives Sanofi rights to market a JHL clinical-stage rituximab biosimilar, initially for China.
In this article: AZN, NVS, SNY, CGIX, BGNE
Read

PARTNER HEADLINES

Latest Tweets for $NVS

No tweets yet!